Vivos Therapeutics, Inc. ( VVOS) - Key Metrics
VVOS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.29 | -$0.31 | -$0.18 | -$0.18 |
| 2026Q1 | $0.35 | -$0.53 | -$0.41 | -$0.41 |
| 2025Q4 | $0.41 | -$0.75 | -$0.41 | -$0.51 |
| 2025Q3 | $0.62 | -$0.49 | -$0.38 | -$0.37 |
| 2025Q2 | $0.42 | -$0.55 | -$0.38 | -$0.47 |
VVOS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.37 |
| 2026Q1 | 0% | -0.57 |
| 2025Q4 | 0% | -0.69 |
| 2025Q3 | 0% | -1.58 |
| 2025Q2 | 0% | -1.44 |
VVOS
Price: $0.18
52 week price:
Earnings Per Share: -1.88 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 77800
Market Capitalization: 2.6 million